Document is current
Any future updates will be listed below
-
Authors
Heyne, H. O. https://orcid.org/0000-0001-9893-3850
Karjalainen, J.
Karczewski, K. J. https://orcid.org/0000-0003-2878-4671
Lemmelä, S. M.
Zhou, W. https://orcid.org/0000-0001-7719-0859
,
Havulinna, A. S. https://orcid.org/0000-0002-4787-8959
Kurki, M.
Rehm, H. L. https://orcid.org/0000-0002-6025-0015
Palotie, A. https://orcid.org/0000-0002-2527-5874
Daly, M. J. https://orcid.org/0000-0002-0949-8752
- License Information
-
More Information
Article History
Received: 28 April 2021
Accepted: 6 October 2022
First Online: 18 January 2023
Competing interests
: A.P. is a member of the Pfizer Genetics Scientific Advisory Panel. M.J.D. is a founder of Maze Therapeutics. The remaining authors declare no competing interests.
